Efficacy of Albuterol SPIROMAX® in Patients With Exercise-Induced Bronchoconstriction

Study Title
Efficacy of Albuterol SPIROMAXֲ® in Adult and Adolescent Patients With Exercise-Induced Bronchoconstriction (EIB)
Teva Identifier
ABS-AS-302
ClinicalTrials.gov Identifier
NCT01791972
Study Status
Completed
Trial Condition(s)
Exercise-Induced Bronchoconstriction (EIB)
Interventions
Drug: Albuterol Spiromax | Drug: Placebo Spiromax

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
18 Years to 50 Years
Trial Duration
03/01/2013 - 06/01/2013
Phase
Phase 3

Study Type

Interventional